In early 2023, the FDA approved a second treatment for individuals with Alzheimer disease. Do you believe this approval is a serious breakthrough in the treatment of Alzheimer disease? Voice your opinion...
Guidelines state that 6 weeks of comprehensive multidisciplinary outpatient rehabilitation may be effective for improving disability and/or function in multiple sclerosis (MS). Do you find that outpatient...
Cognitive changes are common among people with multiple sclerosis (MS). How do you screen for cognitive involvement among your patients with MS? Let us know by taking our poll.
Neurology Consultant is a multimedia platform for neurologists and other health care providers who treat neurological conditions. Tell us about your favorite content and what content of which you want...
Lowering blood pressure is one way to reduce an individual’s risk of stroke. But when is the optimal time to lower blood pressure in an individual who has just had a stroke? Let us know by taking our poll.
...
Research on stem cell therapy has shown promise as a therapy for multiple sclerosis. Which type of stem cells do you think shows the most promise for patients with advanced multiple sclerosis?
It is sometimes challenging to capture multiple sclerosis disease activity and, therefore, to track the efficacy of interventions. Do you think current measures are relevant for assessing intervention...
Clinically isolated syndrome (CIS) is a first episode of neurologic symptoms that lasts at least 24 hours and is caused by inflammation or demyelination in the central nervous system. Do you think testing...
